Td Waterhouse Canada Inc. Ascendis Pharma A/S Transaction History
Td Waterhouse Canada Inc.
- $14.8 Trillion
- Q2 2024
A detailed history of Td Waterhouse Canada Inc. transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Td Waterhouse Canada Inc. holds 164 shares of ASND stock, worth $21,167. This represents 0.0% of its overall portfolio holdings.
Number of Shares
164
Previous 164
-0.0%
Holding current value
$21,167
Previous $24 Million
36.66%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ASND
# of Institutions
223Shares Held
56.6MCall Options Held
142KPut Options Held
259K-
Ra Capital Management, L.P. Boston, MA10.1MShares$1.3 Billion20.78% of portfolio
-
Westfield Capital Management CO LP Boston, MA4.96MShares$641 Million3.41% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI4.3MShares$554 Million0.93% of portfolio
-
Avoro Capital Advisors LLC New York, NY4.2MShares$542 Million7.81% of portfolio
-
Janus Henderson Group PLC London, X03.92MShares$506 Million0.29% of portfolio
About Ascendis Pharma A/S
- Ticker ASND
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,810,200
- Market Cap $7.2B
- Description
- Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...